Chemotherapy Induced Peripheral Neuropathy Treatment Market Key Driver, Key Developments, Trends, Product, Region, Challenges and Forecast to 2025
CIPN is a common adverse effect of several cancer therapies including taxanes and platinum drugs. Symptoms include decreased sensation and tingling of the hands and feet, severe pain, numbness and muscle weakness, all of which can occur during cancer treatment, and frequently persist after chemotherapy has ended.
View full press release